SOURCE: Cypress Bioscience, Inc.

November 27, 2007 06:30 ET

Cypress Bioscience, Inc. to Present at CIBC World Markets 3rd Annual Mid & Small Cap 'Best Ideas' Conference

SAN DIEGO, CA--(Marketwire - November 27, 2007) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Michael Hufford, PhD, its VP of Corporate Development, will present at CIBC World Markets 3rd Annual Mid & Small Cap 'Best Ideas' Conference on Wednesday, November 28, 2007.

The CIBC conference is being held at the Millennium Broadway Hotel, New York, NY. Dr. Hufford is scheduled to present on Wednesday, November 28th at 8:00 a.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience, Inc.

Cypress is committed to being an innovator and leader in providing products for the treatment of patients with Fibromyalgia Syndrome (FMS). We continue to evaluate various other potential strategic transactions, including the potential acquisition of products, product candidates, technologies and companies.

For more information about Cypress, please visit the Company's web site at

Contact Information

  • For additional information please contact
    For Cypress Bioscience:
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer
    Mary Gieson
    Investor Relations
    (858) 452-2323